Exploring a Drug-Free Skinny Pill Mimicking Ozempic’s Effects – Scientists are exploring the development of a drug-free, oral version of the skinny pill, akin to Ozempic, which is designed to trick the body into feeling full, thereby promoting weight loss. This innovation is part of a broader trend in the pharmaceutical industry to offer more accessible and convenient treatments for obesity and related conditions.
Ozempic, a medication known for its ability to induce weight loss, is currently administered as an injection. Its main ingredient, semaglutide, is also available in a pill form under the name Rybelsus, which is approved for treating Type 2 diabetes. However, the pill version is at a lower dose and may cause more side effects compared to the injections.
The ongoing clinical trials are focusing on developing an oral version of Ozempic that could potentially be as effective as the injectable form for weight loss. This is despite Ozempic being primarily approved for managing Type 2 diabetes. The trials are exploring three different pill versions, each with unique ingredients, from Novo Nordisk, Eli Lilly, and Pfizer. These pills are being studied for their potential effectiveness in weight loss, indicating a significant shift in the approach to treating obesity.
One of the pills under study, danuglipron, is a GLP-1 antagonist like Ozempic and Wegovy. Clinical trial results have shown that participants taking danuglipron twice daily experienced statistically significant weight reduction compared to a placebo after 16 weeks, without the need for fasting before taking the pill. This suggests that oral medications could be a viable alternative to injections for weight loss.
Novo Nordisk, the manufacturer of Ozempic, is expected to seek approval for an oral pill version of semaglutide in 2023. This version is a higher dose than Rybelsus and has shown promising results in clinical trials, with participants losing an average of 15% of their body weight after 68 weeks. The side effects reported were similar to those seen with the injection, indicating that the oral form could be a practical option for many patients.
Eli Lilly’s orforglipron, another GLP-1 receptor agonist, has also shown promising results in clinical trials. Participants taking orforglipron lost between 9.4% to 14.7% of their body weight after 36 weeks, suggesting that oral medications could be comparable to approved GLP-1s in terms of effectiveness.
The development of these oral weight loss pills represents a significant advancement in the treatment of obesity. By offering a more accessible and convenient alternative to injections, these pills could make weight loss treatments more accessible to a wider range of patients. However, it’s important to note that more research is needed to fully understand the long-term effects and efficacy of these new medications [ Source].
Side effects of Ozempic
The side effects of Ozempic include common symptoms such as nausea, diarrhea, stomach (abdominal) pain, vomiting, and constipation. Additionally, more serious but less common side effects may include pancreatitis, gastroparesis, bowel obstruction, gallstone attacks, and bile duct blockage.
It is important to seek medical attention if experiencing severe vomiting and diarrhea, severe abdominal pain, inability to pass gas or move bowels, or jaundice while using Ozempic. Regular monitoring and communication with a healthcare provider are essential to manage and address any potential side effects associated with Ozempic use.
What are the potential benefits of the drug-free skinny pill
The potential benefits of the drug-free skinny pill being trialed, like retatrutide, include significant weight loss effects that surpass those of existing weight loss medications. In a phase 2 trial, participants who received the highest dose of retatrutide lost an average of 17.5% of their body weight after 24 weeks and 24.2% after 48 weeks, equivalent to around 41 to 58 pounds.
This pill aims to harness the body’s natural mechanisms related to food metabolism and satiety signaling, offering a non-pharmacological approach to weight management that could be particularly beneficial for individuals who do not respond well to other weight loss medications or need to lose a substantial amount of weight.
Additionally, the sustained weight loss observed in the trial suggests the potential for continued effectiveness over an extended period with healthy lifestyle choices.
ALSO READ: TikTok Users Claim Ozempic Relieves Period Pain: Here’s The Facts To Know Before Going For It
